Education
About Us
Working with TipRanks
Follow Us
Avanos Medical (AVNS)
NYSE:AVNS
Earnings Data
Report Date
Aug 12, 2025TBA Not Confirmed
Period Ending
2025 (Q2)Consensus EPS Forecast
0.15Last Year’s EPS
0.29Same Quarter Last Year
Based on 2 Analysts Ratings
Earnings Call Summary
Earnings Call Date:May 06, 2025
|% Change Since: 0.98%
|Next Earnings Date:Aug 12, 2025
Earnings Call Sentiment|Neutral
Avanos showed strong performance in key segments like Specialty Nutrition Systems and Pain Management, along with a solid financial position. However, significant challenges remain due to tariff impacts and declines in certain product lines, which are expected to affect earnings.Company Guidance
During the Avanos Medical First Quarter 2025 Earnings Call, the company provided comprehensive guidance and discussed various metrics. Avanos reported approximately $168 million in sales for the quarter, with organic sales growth of 2.8% year-over-year. The adjusted diluted earnings per share stood at $0.26, accompanied by an adjusted EBITDA of around $22 million. The adjusted gross margins were 56.7%, while SG&A expenses accounted for 43.4% of revenue. The company's strong balance sheet featured $97 million in cash and $107 million in debt as of March 31. Avanos generated $19 million in free cash flow during the quarter and aims for approximately $65 million for the full year, excluding the impact of tariffs. The Specialty Nutrition Systems segment achieved nearly 9% organic growth, while the Pain Management and Recovery segment saw normalized organic sales rise by 2.4%. However, the company projected tariff-related costs of about $15 million for the year, potentially impacting earnings, and revised its 2025 adjusted earnings per share estimate to a range of $0.75 to $0.95.Strong Performance of Specialty Nutrition Systems
The Specialty Nutrition Systems segment delivered above-market results, growing almost 9% organically versus the prior year, reaffirming their number one position in long-term, short-term, and neonatal enteral feeding.
Positive Growth in Pain Management and Recovery Segment
The Radio Frequency Ablation business posted near double-digit growth this quarter compared to the previous year, with increasing productivity and international expansion leveraging reimbursement tailwinds.
Solid Financial Position
Avanos reported $97 million of cash-on-hand and $107 million of debt outstanding as of March 31. They generated $19 million of free cash flow in the quarter and estimate $65 million for 2025, excluding tariffs.
AVNS Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
AVNS Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
May 06, 2025 | $12.19 | $12.85 | +5.41% |
Feb 26, 2025 | $15.56 | $15.62 | +0.39% |
Oct 30, 2024 | $22.63 | $18.58 | -17.90% |
Jul 31, 2024 | $22.96 | $23.92 | +4.18% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Avanos Medical (AVNS) report earnings?
Avanos Medical (AVNS) is schdueled to report earning on Aug 12, 2025, TBA Not Confirmed.
What is Avanos Medical (AVNS) earnings time?
Avanos Medical (AVNS) earnings time is at Aug 12, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is AVNS EPS forecast?
AVNS EPS forecast for the fiscal quarter 2025 (Q2) is 0.15.